BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee PY, Platt CD, Weeks S, Grace RF, Maher G, Gauthier K, Devana S, Vitali S, Randolph AG, McDonald DR, Geha RS, Chou J. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol 2020;146:1194-1200.e1. [PMID: 32853638 DOI: 10.1016/j.jaci.2020.07.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin B, Goldbach-Mansky R. Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies. J Allergy Clin Immunol 2021:S0091-6749(21)01685-7. [PMID: 34893352 DOI: 10.1016/j.jaci.2021.10.027] [Reference Citation Analysis]
2 Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee. J Clin Immunol 2021;41:666-79. [PMID: 33598806 DOI: 10.1007/s10875-021-00980-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 22.0] [Reference Citation Analysis]
3 Yoshimura A, Aki D, Ito M. SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:277-91. [PMID: 34121041 DOI: 10.2183/pjab.97.016] [Reference Citation Analysis]
4 Ronit A, Jørgensen SE, Roed C, Eriksson R, Iepsen UW, Plovsing RR, Storgaard M, Gustafsson F, Hansen AE, Mogensen TH. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome. Front Immunol 2021;12:718744. [PMID: 34531865 DOI: 10.3389/fimmu.2021.718744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Schvartz A, Belot A, Kone-Paut I. Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic. Front Pediatr 2020;8:605807. [PMID: 33344389 DOI: 10.3389/fped.2020.605807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
6 Felsenstein S, Willis E, Lythgoe H, McCann L, Cleary A, Mahmood K, Porter D, Jones J, McDonagh J, Chieng A, Varnier G, Hughes S, Boullier M, Ryan F, Awogbemi O, Soda G, Duong P, Pain C, Riley P, Hedrich CM. Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS). J Clin Med 2020;9:E3293. [PMID: 33066459 DOI: 10.3390/jcm9103293] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
7 Moreews M, Le Gouge K, Khaldi-Plassart S, Pescarmona R, Mathieu AL, Malcus C, Djebali S, Bellomo A, Dauwalder O, Perret M, Villard M, Chopin E, Rouvet I, Vandenesh F, Dupieux C, Pouyau R, Teyssedre S, Guerder M, Louazon T, Moulin-Zinsch A, Duperril M, Patural H, Giovannini-Chami L, Portefaix A, Kassai B, Venet F, Monneret G, Lombard C, Flodrops H, De Guillebon JM, Bajolle F, Launay V, Bastard P, Zhang SY, Dubois V, Thaunat O, Richard JC, Mezidi M, Allatif O, Saker K, Dreux M, Abel L, Casanova JL, Marvel J, Trouillet-Assant S, Klatzmann D, Walzer T, Mariotti-Ferrandiz E, Javouhey E, Belot A. Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children. Sci Immunol 2021;6:eabh1516. [PMID: 34035116 DOI: 10.1126/sciimmunol.abh1516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr 2021;33:648-56. [PMID: 34734915 DOI: 10.1097/MOP.0000000000001062] [Reference Citation Analysis]
9 Zhang M, Fang Y, Xu P, Dong L, Shen R, Huang Y, Fu D, Yan Z, Cheng S, Jiang X, Song Q, He Y, Zhao Y, Lu M, Ye J, Liu F, Cheng L, Wang C, Wang L, Zhao W. Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study. Clinical & Translational Med 2021;11. [DOI: 10.1002/ctm2.584] [Reference Citation Analysis]
10 Hadjadj J, Frémond ML, Neven B. Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity. Front Immunol 2021;12:717388. [PMID: 34603291 DOI: 10.3389/fimmu.2021.717388] [Reference Citation Analysis]
11 Goudouris ES, Pinto-Mariz F, Mendonça LO, Aranda CS, Guimarães RR, Kokron C, Barros MT, Anísio F, Alonso MLO, Marcelino F, Valle SOR, Junior SD, Barreto IDP, Ferreira JFS, Roxo-Junior P, do Rego Silva AM, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Di Gesu RSW, Schidlowski L, Fillipo P, Bichuetti-Silva DC, Soldateli G, Ferraroni NR, de Oliveira Dantas E, Pestana S, Mansour E, Ulaf RG, Prando C, Condino-Neto A, Grumach AS. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study. J Clin Immunol 2021. [PMID: 34164762 DOI: 10.1007/s10875-021-01066-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Santos MO, Gonçalves LC, Silva PAN, Moreira ALE, Ito CRM, Peixoto FAO, Wastowski IJ, Carneiro LC, Avelino MAG. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J) 2021:S0021-7557(21)00148-0. [PMID: 34863701 DOI: 10.1016/j.jped.2021.08.006] [Reference Citation Analysis]
13 Giardino G, Romano R, Coppola E, Cillo F, Borzachiello C, De Luca M, Palamaro L, Toriell E, Prencipe R, Cirillo E, Pignata C. SARS-CoV-2 infection in the immunodeficient host: necessary and dispensable immune pathways. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00778-9. [PMID: 34273582 DOI: 10.1016/j.jaip.2021.06.045] [Reference Citation Analysis]
14 Ren A, Yin W, Miller H, Westerberg LS, Candotti F, Park CS, Lee P, Gong Q, Chen Y, Liu C. Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity. Front Immunol 2021;12:725587. [PMID: 34512655 DOI: 10.3389/fimmu.2021.725587] [Reference Citation Analysis]
15 Körholz J, Gabrielyan A, Sowerby JM, Boschann F, Chen LS, Paul D, Brandt D, Kleymann J, Kolditz M, Toepfner N, Knöfler R, Jacobsen EM, Wolf C, Conrad K, Röber N, Lee-Kirsch MA, Smith KGC, Mundlos S, Berner R, Dalpke AH, Schuetz C, Rae W. One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency. Front Immunol 2021;12:680334. [PMID: 34421895 DOI: 10.3389/fimmu.2021.680334] [Reference Citation Analysis]
16 Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med 2020;:1-11. [PMID: 32984764 DOI: 10.1007/s42399-020-00521-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
17 Demirdag Y, Fuleihan R, Orange JS, Yu JE. New primary immunodeficiencies 2021 context and future. Curr Opin Pediatr 2021;33:657-75. [PMID: 34670265 DOI: 10.1097/MOP.0000000000001075] [Reference Citation Analysis]
18 Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, Giovannini-Chami L, Wood N, Chandler RE, Klein NP, Schlaudecker EP, Poli MC, Muscal E, Munoz FM. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;. [PMID: 33640145 DOI: 10.1016/j.vaccine.2021.01.054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
19 Yoshimura A, Ito M, Mise-Omata S, Ando M. SOCS: negative regulators of cytokine signaling for immune tolerance. Int Immunol 2021:dxab055. [PMID: 34415326 DOI: 10.1093/intimm/dxab055] [Reference Citation Analysis]
20 Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, Peters Z, Day-Lewis M, Novak T, Armant M, Williams L, Rockowitz S, Sliz P, Williams DA, Randolph AG, Geha RS; Taking on COVID-19 Together Study Investigators. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol 2021:S0091-6749(21)01052-6. [PMID: 34224783 DOI: 10.1016/j.jaci.2021.06.024] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
21 Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Reference Citation Analysis]
22 Tangye SG, Bucciol G, Meyts I. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity. Curr Opin Allergy Clin Immunol 2021;21:515-24. [PMID: 34494617 DOI: 10.1097/ACI.0000000000000786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr 2021;33:549-55. [PMID: 34534994 DOI: 10.1097/MOP.0000000000001061] [Reference Citation Analysis]
24 Johnson HM, Lewin AS, Ahmed CM. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19. Front Immunol 2020;11:582102. [PMID: 33193390 DOI: 10.3389/fimmu.2020.582102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021;17:731-48. [PMID: 34716418 DOI: 10.1038/s41584-021-00709-9] [Reference Citation Analysis]
26 Bigley TM, Cooper MA. Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation. Curr Opin Immunol 2021;72:230-8. [PMID: 34265589 DOI: 10.1016/j.coi.2021.06.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Vella LA, Rowley AH. Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr Pediatr Rep 2021;:1-10. [PMID: 34692237 DOI: 10.1007/s40124-021-00257-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]